rs1573643
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_002569.4(FURIN):c.667+128T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.316 in 694,376 control chromosomes in the GnomAD database, including 36,577 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.33 ( 8595 hom., cov: 33)
Exomes 𝑓: 0.31 ( 27982 hom. )
Consequence
FURIN
NM_002569.4 intron
NM_002569.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.382
Publications
17 publications found
Genes affected
FURIN (HGNC:8568): (furin, paired basic amino acid cleaving enzyme) This gene encodes a member of the subtilisin-like proprotein convertase family, which includes proteases that process protein and peptide precursors trafficking through regulated or constitutive branches of the secretory pathway. It encodes a type 1 membrane bound protease that is expressed in many tissues, including neuroendocrine, liver, gut, and brain. The encoded protein undergoes an initial autocatalytic processing event in the ER and then sorts to the trans-Golgi network through endosomes where a second autocatalytic event takes place and the catalytic activity is acquired. Like other members of this convertase family, the product of this gene specifically cleaves substrates at single or paired basic residues. Some of its substrates include proparathyroid hormone, transforming growth factor beta 1 precursor, proalbumin, pro-beta-secretase, membrane type-1 matrix metalloproteinase, beta subunit of pro-nerve growth factor and von Willebrand factor. It is thought to be one of the proteases responsible for the activation of HIV envelope glycoproteins gp160 and gp140, and may play a role in tumor progression. Unlike SARS-CoV and other coronaviruses, the spike protein of SARS-CoV-2 is thought to be uniquely cleaved by this protease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.389 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FURIN | NM_002569.4 | c.667+128T>C | intron_variant | Intron 7 of 15 | ENST00000268171.8 | NP_002560.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FURIN | ENST00000268171.8 | c.667+128T>C | intron_variant | Intron 7 of 15 | 1 | NM_002569.4 | ENSP00000268171.2 |
Frequencies
GnomAD3 genomes AF: 0.329 AC: 49967AN: 152026Hom.: 8583 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
49967
AN:
152026
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.312 AC: 169238AN: 542232Hom.: 27982 AF XY: 0.312 AC XY: 87577AN XY: 280730 show subpopulations
GnomAD4 exome
AF:
AC:
169238
AN:
542232
Hom.:
AF XY:
AC XY:
87577
AN XY:
280730
show subpopulations
African (AFR)
AF:
AC:
5675
AN:
14250
American (AMR)
AF:
AC:
4134
AN:
20774
Ashkenazi Jewish (ASJ)
AF:
AC:
5147
AN:
14634
East Asian (EAS)
AF:
AC:
3125
AN:
30680
South Asian (SAS)
AF:
AC:
13292
AN:
47444
European-Finnish (FIN)
AF:
AC:
9001
AN:
33170
Middle Eastern (MID)
AF:
AC:
1179
AN:
3398
European-Non Finnish (NFE)
AF:
AC:
118593
AN:
348874
Other (OTH)
AF:
AC:
9092
AN:
29008
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
5994
11988
17981
23975
29969
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1644
3288
4932
6576
8220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.329 AC: 50007AN: 152144Hom.: 8595 Cov.: 33 AF XY: 0.322 AC XY: 23965AN XY: 74390 show subpopulations
GnomAD4 genome
AF:
AC:
50007
AN:
152144
Hom.:
Cov.:
33
AF XY:
AC XY:
23965
AN XY:
74390
show subpopulations
African (AFR)
AF:
AC:
16330
AN:
41486
American (AMR)
AF:
AC:
4025
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
1228
AN:
3472
East Asian (EAS)
AF:
AC:
488
AN:
5180
South Asian (SAS)
AF:
AC:
1263
AN:
4822
European-Finnish (FIN)
AF:
AC:
2743
AN:
10602
Middle Eastern (MID)
AF:
AC:
95
AN:
294
European-Non Finnish (NFE)
AF:
AC:
22873
AN:
67976
Other (OTH)
AF:
AC:
698
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1720
3440
5159
6879
8599
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
486
972
1458
1944
2430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
728
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.